[SCHEDULE 13G/A] Anteris Technologies Global Corp. SEC Filing
Anteris Technologies Global Corp. received a Schedule 13G/A disclosing that Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. and Joseph Edelman collectively beneficially own 1,705,130 shares of the issuer's common stock, representing 4.7% of the outstanding class based on 36,062,370 shares outstanding. The Master Fund directly holds the shares; Perceptive Advisors is the fund's investment manager and Mr. Edelman is the managing member, and each may be deemed to beneficially own the shares. No sole voting or dispositive power is reported; all voting and dispositive power is shared.
Anteris Technologies Global Corp. ha ricevuto un Schedule 13G/A che indica che Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. e Joseph Edelman detengono congiuntamente la propriet脿 beneficiaria di 1.705.130 azioni del capitale sociale dell'emittente, pari al 4,7% della classe in circolazione su un totale di 36.062.370 azioni in circolazione. Le azioni sono detenute direttamente dal Master Fund; Perceptive Advisors 猫 il gestore degli investimenti del fondo e il sig. Edelman 猫 il membro amministratore, perci貌 ciascuno pu貌 essere considerato beneficiario delle azioni. Non 猫 riportato alcun potere di voto o dispositive esclusivo; tutti i poteri di voto e dispositivi sono esercitati congiuntamente.
Anteris Technologies Global Corp. recibi贸 un Schedule 13G/A que revela que Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. y Joseph Edelman poseen colectivamente la propiedad beneficiaria de 1.705.130 acciones ordinarias de la emisora, lo que representa el 4,7% de la clase en circulaci贸n sobre 36.062.370 acciones en circulaci贸n. El Master Fund posee directamente las acciones; Perceptive Advisors es el gestor de inversiones del fondo y el Sr. Edelman es el miembro administrador, por lo que cada uno puede considerarse beneficiario de las acciones. No se informa de poder exclusivo de voto o disposici贸n; todos los poderes de voto y disposici贸n son compartidos.
Anteris Technologies Global Corp.電� Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. 氚� Joseph Edelman鞚� 頃粯 氚滍枆須岇偓鞚� 氤错喌欤� 1,705,130欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨潓鞚� 瓿店皽頃� Schedule 13G/A毳� 鞝戩垬頄堨溂氅�, 鞚措姅 齑� 36,062,370欤� 欷� 鞙犿喌欤检嫕鞚� 4.7%鞐� 頃措嫻頃╇媹雼�. 頃措嫻 欤检嫕鞚� Master Fund臧� 歆侅爲 氤挫湢頃橁碃 鞛堨溂氅� Perceptive Advisors電� 攴� 韼�霌滌潣 韴瀽毵る媹鞝�, Edelman 鞌姅 鞖挫榿 氅る矂搿滌劀 臧侅瀽 欤检嫕鞚� 鞁れ鞝侅溂搿� 氤挫湢頃� 瓴冹溂搿� 臧勳＜霅� 靾� 鞛堨姷雼堧嫟. 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇潃 氤搓碃霅橃 鞎婌晿鞙茧┌, 氇摖 鞚橁舶甓� 氚� 觳橂秳甓岇潃 瓿惦彊鞙茧 氤挫湢霅╇媹雼�.
Anteris Technologies Global Corp. a re莽u un Schedule 13G/A r茅v茅lant que Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. et Joseph Edelman d茅tiennent conjointement la propri茅t茅 b茅n茅ficiaire de 1 705 130 actions ordinaires de l'茅metteur, repr茅sentant 4,7 % de la cat茅gorie en circulation sur un total de 36 062 370 actions en circulation. Le Master Fund d茅tient directement les actions ; Perceptive Advisors est le gestionnaire d'investissement du fonds et M. Edelman est le membre gestionnaire, de sorte que chacun peut 锚tre consid茅r茅 comme b茅n茅ficiaire des actions. Aucun pouvoir exclusif de vote ou de disposition n'est d茅clar茅 ; tous les pouvoirs de vote et de disposition sont partag茅s.
Anteris Technologies Global Corp. erhielt ein Schedule 13G/A, das offenlegt, dass Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. und Joseph Edelman gemeinsam 1.705.130 Aktien der Stammaktien des Emittenten wirtschaftlich besitzen, was 4,7% der ausstehenden Klasse bei insgesamt 36.062.370 ausstehenden Aktien entspricht. Die Aktien werden direkt vom Master Fund gehalten; Perceptive Advisors ist der Investmentmanager des Fonds und Herr Edelman ist das gesch盲ftsf眉hrende Mitglied, sodass jeder von ihnen als wirtschaftlicher Eigent眉mer der Aktien angesehen werden kann. Alleinige Stimm- oder Verf眉gungsgewalt wird nicht angegeben; Stimm- und Verf眉gungsrechte werden gemeinschaftlich ausge眉bt.
- Clear disclosure of beneficial ownership totaling 1,705,130 shares
- Ownership percentage provided (4.7% of 36,062,370 shares outstanding)
- Signatures and certifications included from the reporting persons
- None.
Insights
TL;DR: A 4.7% passive stake disclosed by an investment manager and affiliated fund; below the 5% reportable threshold for control but material for ownership monitoring.
The filing shows the Master Fund directly holds 1,705,130 shares (4.7%) with no sole voting or dispositive power reported and all voting/dispositive power listed as shared. Perceptive Advisors, as manager, and Joseph Edelman, as managing member, are identified as persons who may be deemed to beneficially own these shares. The statement is presented on Schedule 13G/A, indicating a passive investor reporting under the applicable rule set rather than an activist 13D filing. This is a straightforward disclosure of ownership useful for cap table tracking and shareholder concentration analysis.
TL;DR: Disclosure clarifies beneficial ownership and voting arrangements but indicates no controlling stake or sole authority.
The report attributes shared voting and dispositive power to the reporting entities while showing zero sole power, which suggests decisions over these shares are not unilaterally controlled by the filer. The filing includes the issuer address and references the outstanding share count used to calculate the 4.7% figure. It contains standard certifications and signatures from Joseph Edelman for all reporting persons, consistent with regulatory requirements.
Anteris Technologies Global Corp. ha ricevuto un Schedule 13G/A che indica che Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. e Joseph Edelman detengono congiuntamente la propriet脿 beneficiaria di 1.705.130 azioni del capitale sociale dell'emittente, pari al 4,7% della classe in circolazione su un totale di 36.062.370 azioni in circolazione. Le azioni sono detenute direttamente dal Master Fund; Perceptive Advisors 猫 il gestore degli investimenti del fondo e il sig. Edelman 猫 il membro amministratore, perci貌 ciascuno pu貌 essere considerato beneficiario delle azioni. Non 猫 riportato alcun potere di voto o dispositive esclusivo; tutti i poteri di voto e dispositivi sono esercitati congiuntamente.
Anteris Technologies Global Corp. recibi贸 un Schedule 13G/A que revela que Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. y Joseph Edelman poseen colectivamente la propiedad beneficiaria de 1.705.130 acciones ordinarias de la emisora, lo que representa el 4,7% de la clase en circulaci贸n sobre 36.062.370 acciones en circulaci贸n. El Master Fund posee directamente las acciones; Perceptive Advisors es el gestor de inversiones del fondo y el Sr. Edelman es el miembro administrador, por lo que cada uno puede considerarse beneficiario de las acciones. No se informa de poder exclusivo de voto o disposici贸n; todos los poderes de voto y disposici贸n son compartidos.
Anteris Technologies Global Corp.電� Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. 氚� Joseph Edelman鞚� 頃粯 氚滍枆須岇偓鞚� 氤错喌欤� 1,705,130欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨潓鞚� 瓿店皽頃� Schedule 13G/A毳� 鞝戩垬頄堨溂氅�, 鞚措姅 齑� 36,062,370欤� 欷� 鞙犿喌欤检嫕鞚� 4.7%鞐� 頃措嫻頃╇媹雼�. 頃措嫻 欤检嫕鞚� Master Fund臧� 歆侅爲 氤挫湢頃橁碃 鞛堨溂氅� Perceptive Advisors電� 攴� 韼�霌滌潣 韴瀽毵る媹鞝�, Edelman 鞌姅 鞖挫榿 氅る矂搿滌劀 臧侅瀽 欤检嫕鞚� 鞁れ鞝侅溂搿� 氤挫湢頃� 瓴冹溂搿� 臧勳＜霅� 靾� 鞛堨姷雼堧嫟. 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇潃 氤搓碃霅橃 鞎婌晿鞙茧┌, 氇摖 鞚橁舶甓� 氚� 觳橂秳甓岇潃 瓿惦彊鞙茧 氤挫湢霅╇媹雼�.
Anteris Technologies Global Corp. a re莽u un Schedule 13G/A r茅v茅lant que Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. et Joseph Edelman d茅tiennent conjointement la propri茅t茅 b茅n茅ficiaire de 1 705 130 actions ordinaires de l'茅metteur, repr茅sentant 4,7 % de la cat茅gorie en circulation sur un total de 36 062 370 actions en circulation. Le Master Fund d茅tient directement les actions ; Perceptive Advisors est le gestionnaire d'investissement du fonds et M. Edelman est le membre gestionnaire, de sorte que chacun peut 锚tre consid茅r茅 comme b茅n茅ficiaire des actions. Aucun pouvoir exclusif de vote ou de disposition n'est d茅clar茅 ; tous les pouvoirs de vote et de disposition sont partag茅s.
Anteris Technologies Global Corp. erhielt ein Schedule 13G/A, das offenlegt, dass Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. und Joseph Edelman gemeinsam 1.705.130 Aktien der Stammaktien des Emittenten wirtschaftlich besitzen, was 4,7% der ausstehenden Klasse bei insgesamt 36.062.370 ausstehenden Aktien entspricht. Die Aktien werden direkt vom Master Fund gehalten; Perceptive Advisors ist der Investmentmanager des Fonds und Herr Edelman ist das gesch盲ftsf眉hrende Mitglied, sodass jeder von ihnen als wirtschaftlicher Eigent眉mer der Aktien angesehen werden kann. Alleinige Stimm- oder Verf眉gungsgewalt wird nicht angegeben; Stimm- und Verf眉gungsrechte werden gemeinschaftlich ausge眉bt.
FAQ
How many shares of Anteris Technologies (AVR) do Perceptive Advisors and affiliates report owning?
Does the filing show sole voting or dispositive power for the reported shares?
Which entities and individuals are listed as reporting persons on this Schedule 13G/A?
What share count was used to calculate the ownership percentage?
Where is the issuer's principal executive office listed in the filing?
